Skip to main content
. Author manuscript; available in PMC: 2014 Jan 29.
Published in final edited form as: Leuk Lymphoma. 2008 Jun;49(6):1074–1080. doi: 10.1080/10428190801993470

Table II.

Maximal response to R-DHAP by disease type.

Overall response rate (%) Complete remission rate (%) Partial remission rate (%)
All patients (n=57) 82 33 49
Aggressive (n=38) 82 42 40
Indolent (n=14) 86 14 71
Unclassifiable (n=5) 80 20 60